pteridines has been researched along with Carcinogenesis in 4 studies
Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Plk1, which has been validated as a cancer target, came into the focus of many pharmaceutical companies for the development of small-molecule inhibitors as anticancer agents." | 2.53 | The role of Plk3 in oncogenesis. ( Becker, S; Helmke, C; Strebhardt, K, 2016) |
| "Utilizing breast cancer cells MCF-7, MDA-MB-231 and BT549, cell proliferation, migration and invasion were detected." | 1.56 | Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling. ( Gao, N; He, Q; Ji, J; Li, Y; Liu, J; Ma, L; Wang, Q; Yang, R; Zhou, X, 2020) |
| "Glioblastoma (GBM) is the deadliest primary brain tumor that is highly resistant to current treatments." | 1.56 | Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC. ( Chen, G; Deng, Z; Feng, M; Feng, Z; Li, X; Li, Y; Pan, T; Tao, Z; Wang, H; Yin, H; Zhao, G; Zhou, Y, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tian, L | 1 |
| Yao, K | 1 |
| Liu, K | 1 |
| Han, B | 1 |
| Dong, H | 1 |
| Zhao, W | 1 |
| Jiang, W | 1 |
| Qiu, F | 1 |
| Qu, L | 1 |
| Wu, Z | 1 |
| Zhou, B | 1 |
| Zhong, M | 1 |
| Zhao, J | 1 |
| Qiu, X | 1 |
| Zhong, L | 1 |
| Guo, X | 1 |
| Shi, T | 1 |
| Hong, X | 1 |
| Lu, S | 1 |
| Li, Y | 2 |
| Zhou, X | 1 |
| Liu, J | 1 |
| Gao, N | 1 |
| Yang, R | 1 |
| Wang, Q | 1 |
| Ji, J | 1 |
| Ma, L | 1 |
| He, Q | 1 |
| Wang, H | 1 |
| Tao, Z | 1 |
| Feng, M | 1 |
| Li, X | 1 |
| Deng, Z | 1 |
| Zhao, G | 1 |
| Yin, H | 1 |
| Pan, T | 1 |
| Chen, G | 1 |
| Feng, Z | 1 |
| Zhou, Y | 1 |
| Helmke, C | 1 |
| Becker, S | 1 |
| Strebhardt, K | 1 |
1 review available for pteridines and Carcinogenesis
| Article | Year |
|---|---|
The role of Plk3 in oncogenesis.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Carcinogenesis; Cell Cycle Proteins; DNA Damage; Huma | 2016 |
3 other studies available for pteridines and Carcinogenesis
| Article | Year |
|---|---|
PLK1/NF-κB feedforward circuit antagonizes the mono-ADP-ribosyltransferase activity of PARP10 and facilitates HCC progression.
Topics: Animals; Antineoplastic Agents; Carcinogenesis; Carcinoma, Hepatocellular; Cell Cycle Proteins; Dise | 2020 |
Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling.
Topics: Animals; Antineoplastic Agents, Phytogenic; Artemisinins; Breast Neoplasms; Carcinogenesis; Cell Lin | 2020 |
Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Carcinogenesis; Cell Cycle Proteins; Cel | 2020 |